Julie A. Vetalice, Author at ORTHOWORLD

Bio2 Technologies Receives FDA Clearance for Extremities Fusion Implant

Bio2 Technologies received FDA 510(k) clearance to market a fusion system for interphalangeal fusion, fracture repair and osteotomies of toes, fingers and other small bones. Limited product launch is slated for 2Q16.

Jan 11, 2016

MiMedx to Acquire Stability Biologics

Competitive Landscape Mergers & Acquisitions

MiMedx signed a definitive agreement to acquire Stability Biologics for US $10MM in cash and stock. Stability Biologics provides human tissue products for the surgical, spine and orthopaedic industries. The transaction is expected to close in early 1Q16.

Jan 11, 2016

CartiHeal Raises $15 Million

Investments The Numbers

CartiHeal completed a US $15MM financing round. Funds will support ongoing manufacturing scale-up, EU product commercialization in 2017 and clinical studies in new therapeutic areas for Agili-C™ cartilage regeneration technology.

Jan 11, 2016

20,000 Patients Treated with BONESUPPORT’s CERAMENT

Orthobiologics ORTHOFLASH

BONESUPPORT announced the milestone of >20,000 patients treated worldwide to date with CERAMENT™ injectable drug-eluting bone substitute products.

Jan 11, 2016

First Procedure with K2M’s CASCADIA Lateral Interbody System Featuring Lamellar Titanium

ORTHOFLASH Spine

K2M confirmed the first surgical case performed using the CASCADIA™ Lateral Interbody System featuring Lamellar Titanium Technology™, in late 4Q15.

Jan 08, 2016

FDA Clearance Achieved for Next Generation of intellijoint HIP

ORTHOFLASH Robotics/Tech

Intellijoint Surgical received FDA 510(k) clearance to market the next-generation intellijioint HIP™ surgical smart tool, now including cup position (inclination and anteversion).

Jan 07, 2016

Vexim Hits Milestone, 25,000 SpineJack Units Sold

ORTHOFLASH Spine

Vexim achieved a milestone of 25,000 SpineJack® units sold since market launch in 2011.

Jan 07, 2016

MEDTECH Receives FDA Clearance for ROSA Spine Robot

ORTHOFLASH Robotics/Tech

MEDTECH received FDA 510(k) clearance to market the ROSA™ Spine robot assistive system for use in minimally invasive surgical procedures.

Jan 06, 2016

Benvenue Medical Secures $60 Million Financing

Investments The Numbers

Benvenue Medical completed a US $60MM financing round. Proceeds will support U.S. commercialization of the Luna® 3D Interbody Fusion and the Kiva® Vertebral Compression Fracture Treatment systems.

Jan 06, 2016

Vivex Biomedical Raised $6.6MM in Series A Funding

Investments The Numbers

Vivex Biomedical raised US $6.6MM of a potential $10MM offering of Series A Convertible Preferred Stock.

Jan 06, 2016

Get the ORTHOWORLD Newsletter!

Contact Us